HOME >> MEDICINE >> NEWS
NPSF workshop builds community to improve pharmaceutical safety

Chicago, IL - On June 10-11, 1999, the National Patient Safety Foundation (NPSF) will convene a workshop in Washington, DC to design and build consensus around a collaborative action plan to promote pharmaceutical safety. Fifty opinion leaders will participate, representing five key stakeholder groups that can make a difference - the FDA & Government, Medicine & Health Care Practitioners, Pharmacists, Patients & Public Interest Groups, and the Pharmaceutical Industry.

"Each of these groups is working to assure pharmaceutical safety every day. But until all stakeholders in the pharmaceutical safety chain begin to align our strategies and work collaboratively, our efforts will not reach their full potential to maximize benefit and reduce risk and harm to patients," says Eleanor Vogt, RPh, PhD, Senior Fellow of the NPSF. "This workshop provides a neutral forum to leverage the discussion about underlying issues that keep the community from working together to advance safety."

Expected outcomes of this workshop include a collaborative action plan to be released this summer for a pharmaceutical safety initiative. The plan will incorporate the group consensus on the strengths and vulnerabilities of the system, the roles and responsibilities of the major players in the pharmaceutical chain, the existing tools and resources, and the gaps that need to be filled to responsibly address medication safety issues. It will serve as an action agenda for the work of the community as well as the NPSF.

This project is made possible by a public/private partnership reflected in a major grant from Pfizer Inc with additional support from Bristol-Myers Squibb Research Institute, CVS Drug Stores, DuPont Pharmaceuticals Company, the US Food and Drug Administration, the Warner-Lambert company and Janssen Pharmaceutica.

Founded in 1997 by the American Medical Association, CNA HealthPro, 3M, and other partners, the National Patient Safety Foundation is an independent, nonpro
'"/>

Contact: Susan Wagner
susan_wagner@ama-assn.org
312-464-5418
National Patient Safety Foundation
9-Jun-1999


Page: 1 2

Related medicine news :

1. NIH convenes workshop on menopausal hormone therapy
2. Hands-on cancer biology workshop for journalists
3. AAPS kicks off new century with workshop on bioanalytical methods validation
4. PQRI workshop to address blend uniformity
5. AAPS workshop to explore regulatory approaches to bioavailability, bioequivalence
6. AAPS workshop to examine changes in analytical methods and packaging
7. AAPS workshop to explore pharmaceutical reference standards
8. AAPS presents workshop on macromolecules
9. Exercise therapy builds strength, mobility in MS patients
10. Success of experimental herpes vaccine builds momentum for human clinical trials
11. Privacy rule builds biomedical research bottleneck

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NPSF workshop builds community improve pharmaceutical safety

(Date:1/22/2015)... January 22, 2015 Carinsurancesavings.biz has released a ... death and dismemberment insurance . , Purchasing an accidental ... be very advantageous. This type of rider provides benefits if ... can be considered a lesser form of life insurance. ...
(Date:1/22/2015)... Calif. (PRWEB) January 22, 2015 ... Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were ... their leadership in advancing biotechnology, biomedical science, medical ... and Olsen each received the “2014 Life Sciences ...
(Date:1/22/2015)... Four years since the release of their debut recording Love ... of Avasa & Matthew Love – the duo are pleased to ... through White Swan Records on February 24, 2015. , THE ROAD ... available to all of us to walk out of the mire ...
(Date:1/22/2015)... As interest in the value of spiritual ... worldwide, Rev. Eric J. Hall , president and CEO ... will be the keynote speaker on January 27 at an ... system. , The conference, “Hope and Resilience: Innovative and Interdisciplinary ...
(Date:1/22/2015)... Lower-Auto-Insurance.com has released a new blog post explaining the importance of ... the costs of an auto insurance policy . , Clients ... prices for their vehicle insurance policies. The safety a vehicle offers ... Because of this, drivers should always carry a first aid ...
Breaking Medicine News(10 mins):Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
(Date:1/23/2015)... , Jan. 23, 2015  Immune Therapeutics, Inc. today announced ... for the compounding, packaging and distributing of its naltrexone tablets. ... the United States . KRS Global ... naltrexone tablets in various strengths for individual patients in response ...
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that ... of Lixte,s lead compound, LB‑100, is being conducted, has been ... S. Kovach , M.D., the founder and President of Lixte, ... at a single site. Accrual of patients, however, was slower ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
Cached News: